Systematic review and meta-analysis of people with opioid use disorder after withdrawal: pooled 60.3% initiated oral and 18.2% depot naltrexone; 71.0% stopped oral and 60.0% depot by 6 months. Supervised dosing was linked to less oral discontinuation; very low certainty.
Meta-analysis
Roberts et al. Factors associated with the percentage of individuals who initiate and discontinue naltrexone as a relapse prevention pharmacotherapy in opioid use disorder: A systematic review, meta-analysis and meta-regression